IDEXX LABORATORIES INC /DE Interest and Other Income
IDEXX LABORATORIES INC /DE (IDXX) reported Interest and Other Income of $606.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2026-08-04
- IDEXX LABORATORIES INC /DE interest and other income for the quarter ending 2026-06-30 was $606.00K, a 3.35% decline year-over-year.
- IDEXX LABORATORIES INC /DE interest and other income for the quarter ending 2026-03-31 was $597.00K, a 50.90% decline year-over-year.
- IDEXX LABORATORIES INC /DE interest and other income for the quarter ending 2025-12-31 was $587.00K, a 73.31% decline year-over-year.
- IDEXX LABORATORIES INC /DE interest and other income for the quarter ending 2025-09-30 was $580.00K, a 78.63% decline year-over-year.
- IDEXX LABORATORIES INC /DE interest and other income for fiscal 2025 was $3.01M, a 76.30% decline from fiscal 2024.
- IDEXX LABORATORIES INC /DE interest and other income for fiscal 2024 was $12.70M, a 125.60% increase from fiscal 2023.
- IDEXX LABORATORIES INC /DE interest and other income for fiscal 2023 was $5.63M, a 428.54% increase from fiscal 2022.
- IDEXX LABORATORIES INC /DE interest and other income for fiscal 2022 was $1.06M, a 145.39% increase from fiscal 2021.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|
| 2026-06-30 | $606.00K 10-Q · filed 2026-08-04 | $1.20M 10-Q · filed 2026-08-04 | $1.79M derived: sum of 3 quarters · filed 2026-08-04 | $2.37M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $597.00K 10-Q · filed 2026-05-05 | $1.18M derived: sum of 2 quarters · filed 2026-05-05 | $1.76M derived: sum of 3 quarters · filed 2026-05-05 | $2.39M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $587.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $1.17M derived: sum of 2 quarters · filed 2026-02-20 | $1.79M derived: sum of 3 quarters · filed 2026-08-04 | $3.01M 10-K · filed 2026-02-20 |
| 2025-09-30 | $580.00K 10-Q · filed 2025-11-03 | $1.21M derived: sum of 2 quarters · filed 2026-08-04 | $2.42M 10-Q · filed 2025-11-03 | $4.62M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $627.00K 10-Q · filed 2026-08-04 | $1.84M 10-Q · filed 2026-08-04 | $4.04M derived: sum of 3 quarters · filed 2026-08-04 | $6.76M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $1.22M 10-Q · filed 2026-05-05 | $3.42M derived: sum of 2 quarters · filed 2026-05-05 | $6.13M derived: sum of 3 quarters · filed 2026-05-05 | $9.48M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $4.91M derived: sum of 2 quarters · filed 2026-02-20 | $8.27M derived: sum of 3 quarters · filed 2026-02-20 | $12.70M 10-K · filed 2026-02-20 |
| 2024-09-30 | $2.71M 10-Q · filed 2025-11-03 | $6.07M derived: sum of 2 quarters · filed 2025-11-03 | $10.50M 10-Q · filed 2025-11-03 | $14.13M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $3.35M 10-Q · filed 2025-08-04 | $7.79M 10-Q · filed 2025-08-04 | $11.42M derived: sum of 3 quarters · filed 2026-02-20 | $12.67M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $4.43M 10-Q · filed 2025-05-01 | $8.06M derived: sum of 2 quarters · filed 2026-02-20 | $9.32M derived: sum of 3 quarters · filed 2026-02-20 | $9.64M derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $3.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $4.89M derived: sum of 2 quarters · filed 2026-02-20 | $5.21M derived: sum of 3 quarters · filed 2026-02-20 | $5.63M 10-K · filed 2026-02-20 |
| 2023-09-30 | $1.25M 10-Q · filed 2024-10-31 | $1.58M derived: sum of 2 quarters · filed 2024-10-31 | $2.00M 10-Q · filed 2024-10-31 | $2.23M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $327.00K 10-Q · filed 2024-08-06 | $743.00K 10-Q · filed 2024-08-06 | $978.00K derived: sum of 3 quarters · filed 2025-02-21 | $1.33M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $416.00K 10-Q · filed 2024-05-01 | $651.00K derived: sum of 2 quarters · filed 2025-02-21 | $1.00M derived: sum of 3 quarters · filed 2025-02-21 | $1.34M derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-31 | $235.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $588.00K derived: sum of 2 quarters · filed 2025-02-21 | $922.00K derived: sum of 3 quarters · filed 2025-02-21 | $1.06M 10-K · filed 2025-02-21 |
| 2022-09-30 | $353.00K 10-Q · filed 2023-11-01 | $687.00K derived: sum of 2 quarters · filed 2023-11-01 | $830.00K 10-Q · filed 2023-11-01 | $999.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $334.00K 10-Q · filed 2023-08-01 | $477.00K 10-Q · filed 2023-08-01 | $646.00K derived: sum of 3 quarters · filed 2024-02-22 | $768.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $143.00K 10-Q · filed 2023-05-02 | $312.00K derived: sum of 2 quarters · filed 2024-02-22 | $434.00K derived: sum of 3 quarters · filed 2024-02-22 | $525.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $169.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $291.00K derived: sum of 2 quarters · filed 2024-02-22 | $382.00K derived: sum of 3 quarters · filed 2024-02-22 | $434.00K 10-K · filed 2024-02-22 |
| 2021-09-30 | $122.00K 10-Q · filed 2022-11-01 | $213.00K derived: sum of 2 quarters · filed 2022-11-01 | $265.00K 10-Q · filed 2022-11-01 | $434.00K derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $91.00K 10-Q · filed 2022-08-02 | $143.00K 10-Q · filed 2022-08-02 | $312.00K derived: sum of 3 quarters · filed 2023-02-16 | $520.00K derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $52.00K 10-Q · filed 2022-05-04 | $221.00K derived: sum of 2 quarters · filed 2023-02-16 | $429.00K derived: sum of 3 quarters · filed 2023-02-16 | $498.00K derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $169.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $377.00K derived: sum of 2 quarters · filed 2023-02-16 | $446.00K derived: sum of 3 quarters · filed 2023-02-16 | $586.00K 10-K · filed 2023-02-16 |
| 2020-09-30 | $208.00K 10-Q · filed 2021-11-02 | $277.00K derived: sum of 2 quarters · filed 2021-11-02 | $417.00K 10-Q · filed 2021-11-02 | $685.00K derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $69.00K 10-Q · filed 2021-07-30 | $209.00K 10-Q · filed 2021-07-30 | $477.00K derived: sum of 3 quarters · filed 2022-02-16 | $563.00K derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $140.00K 10-Q · filed 2021-05-04 | $408.00K derived: sum of 2 quarters · filed 2022-02-16 | $494.00K derived: sum of 3 quarters · filed 2022-02-16 | $527.00K derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $268.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $354.00K derived: sum of 2 quarters · filed 2022-02-16 | $387.00K derived: sum of 3 quarters · filed 2022-02-16 | $427.00K 10-K · filed 2022-02-16 |
| 2019-09-30 | $86.00K 10-Q · filed 2020-10-29 | $119.00K derived: sum of 2 quarters · filed 2020-10-29 | $159.00K 10-Q · filed 2020-10-29 | $417.00K derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $33.00K 10-Q · filed 2020-07-31 | $73.00K 10-Q · filed 2020-07-31 | $331.00K derived: sum of 3 quarters · filed 2021-02-12 | $473.00K derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $40.00K 10-Q · filed 2020-04-30 | $298.00K derived: sum of 2 quarters · filed 2021-02-12 | $440.00K derived: sum of 3 quarters · filed 2021-02-12 | $612.00K derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $258.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $400.00K derived: sum of 2 quarters · filed 2021-02-12 | $572.00K derived: sum of 3 quarters · filed 2021-02-12 | $1.15M 10-K · filed 2021-02-12 |
| 2018-09-30 | $142.00K 10-Q · filed 2019-10-31 | $314.00K derived: sum of 2 quarters · filed 2019-10-31 | $893.00K 10-Q · filed 2019-10-31 | $2.49M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | $172.00K 10-Q · filed 2019-08-01 | $751.00K 10-Q · filed 2019-08-01 | $2.35M derived: sum of 3 quarters · filed 2020-02-14 | $3.75M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | $579.00K 10-Q · filed 2019-05-01 | $2.17M derived: sum of 2 quarters · filed 2020-02-14 | $3.57M derived: sum of 3 quarters · filed 2020-02-14 | $4.75M derived: sum of 4 quarters · filed 2020-02-14 |
| 2017-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $3.00M derived: sum of 2 quarters · filed 2020-02-14 | $4.17M derived: sum of 3 quarters · filed 2020-02-14 | $5.25M 10-K · filed 2020-02-14 |
| 2017-09-30 | $1.40M 10-Q · filed 2018-11-01 | $2.58M derived: sum of 2 quarters · filed 2018-11-01 | $3.66M 10-Q · filed 2018-11-01 | $4.72M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $1.18M 10-Q · filed 2018-08-01 | $2.26M 10-Q · filed 2018-08-01 | $3.32M derived: sum of 3 quarters · filed 2019-02-15 | $4.17M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $1.08M 10-Q · filed 2018-05-04 | $2.14M derived: sum of 2 quarters · filed 2019-02-15 | $2.99M derived: sum of 3 quarters · filed 2019-02-15 | $3.92M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $1.91M derived: sum of 2 quarters · filed 2019-02-15 | $2.84M derived: sum of 3 quarters · filed 2019-02-15 | $3.66M 10-K · filed 2019-02-15 |
| 2016-09-30 | $851.00K 10-Q · filed 2017-10-31 | $1.78M derived: sum of 2 quarters · filed 2017-10-31 | $2.60M 10-Q · filed 2017-10-31 | $3.40M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $928.00K 10-Q · filed 2017-08-01 | $1.75M 10-Q · filed 2017-08-01 | $2.55M derived: sum of 3 quarters · filed 2018-02-16 | $3.23M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $820.00K 10-Q · filed 2017-04-28 | $1.62M derived: sum of 2 quarters · filed 2018-02-16 | $2.30M derived: sum of 3 quarters · filed 2018-02-16 | $2.86M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $1.48M derived: sum of 2 quarters · filed 2018-02-16 | $2.04M derived: sum of 3 quarters · filed 2018-02-16 | $2.47M 10-K · filed 2018-02-16 |
| 2015-09-30 | $684.00K 10-Q · filed 2016-11-01 | $1.24M derived: sum of 2 quarters · filed 2016-11-01 | $1.67M 10-Q · filed 2016-11-01 | $2.13M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $559.00K 10-Q · filed 2016-08-02 | $984.00K 10-Q · filed 2016-08-02 | $1.44M derived: sum of 3 quarters · filed 2017-02-17 | $1.75M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $425.00K 10-Q · filed 2016-04-29 | $882.00K derived: sum of 2 quarters · filed 2017-02-17 | $1.20M derived: sum of 3 quarters · filed 2017-02-17 | $1.68M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $457.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $770.00K derived: sum of 2 quarters · filed 2017-02-17 | $1.26M derived: sum of 3 quarters · filed 2017-02-17 | $1.73M 10-K · filed 2017-02-17 |
| 2014-09-30 | $313.00K 10-Q · filed 2015-10-28 | $801.00K derived: sum of 2 quarters · filed 2015-10-28 | $1.27M 10-Q · filed 2015-10-28 | $1.81M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-06-30 | $488.00K 10-Q · filed 2015-07-30 | $959.00K 10-Q · filed 2015-07-30 | $1.50M derived: sum of 3 quarters · filed 2016-02-17 | $1.96M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-03-31 | $471.00K 10-Q · filed 2015-04-28 | $1.01M derived: sum of 2 quarters · filed 2016-02-17 | $1.47M derived: sum of 3 quarters · filed 2016-02-17 | $1.91M derived: sum of 4 quarters · filed 2016-02-17 |
| 2013-12-31 | $540.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17 | $996.00K derived: sum of 2 quarters · filed 2016-02-17 | $1.44M derived: sum of 3 quarters · filed 2016-02-17 | $1.89M 10-K · filed 2016-02-17 |
| 2013-09-30 | $456.00K 10-Q · filed 2014-10-24 | $900.00K derived: sum of 2 quarters · filed 2014-10-24 | $1.34M 10-Q · filed 2014-10-24 | $1.86M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $444.00K 10-Q · filed 2014-07-25 | $889.00K 10-Q · filed 2014-07-25 | $1.40M derived: sum of 3 quarters · filed 2015-02-17 | $1.87M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $444.00K 10-Q · filed 2014-04-25 | $957.00K derived: sum of 2 quarters · filed 2015-02-17 | $1.43M derived: sum of 3 quarters · filed 2015-02-17 | $1.91M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $513.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $986.00K derived: sum of 2 quarters · filed 2015-02-17 | $1.47M derived: sum of 3 quarters · filed 2015-02-17 | $1.90M 10-K · filed 2015-02-17 |
| 2012-09-30 | $473.00K 10-Q · filed 2013-10-22 | $953.00K derived: sum of 2 quarters · filed 2013-10-22 | $1.39M 10-Q · filed 2013-10-22 | $1.90M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | $480.00K 10-Q · filed 2013-07-23 | $916.00K 10-Q · filed 2013-07-23 | $1.42M derived: sum of 3 quarters · filed 2014-02-18 | $1.87M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | $436.00K 10-Q · filed 2013-04-23 | $942.00K derived: sum of 2 quarters · filed 2014-02-18 | $1.39M derived: sum of 3 quarters · filed 2014-02-18 | $1.81M derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | $506.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $956.00K derived: sum of 2 quarters · filed 2014-02-18 | $1.38M derived: sum of 3 quarters · filed 2014-02-18 | $1.74M 10-K · filed 2014-02-18 |
| 2011-09-30 | $450.00K 10-Q · filed 2012-10-19 | $869.00K derived: sum of 2 quarters · filed 2012-10-19 | $1.24M 10-Q · filed 2012-10-19 | |
| 2011-06-30 | $419.00K 10-Q · filed 2012-07-20 | $788.00K 10-Q · filed 2012-07-20 | ||
| 2010-12-31 | $663.00K 10-K · filed 2013-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |